Coronary artery disease
Conditions
Interventions
Intervention group:The patients in the experimental group were comprehensively managed using the digital clinical management system independently developed by Chengdu Harriet Medical Technology Co., L
Control group:Without using a digital clinical management system, only the routine post-hospital management after coronary heart disease day-case stent surgery is adopted, which includes routine healt
Sponsors
Northern Jiangsu People's Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Aged between 18 and 65 years inclusive; 2.Diagnosed with coronary artery disease; 3.Underwent day-case stent implantation; 4.Subjects were willing to comply with the study protocol and provided written informed consent.
Exclusion criteria
Exclusion criteria: 1.Patients with planned revascularization within one year; 2.Pregnant or breastfeeding patients, or those planning to become pregnant within one year; 3.Patients with a medical history of non-ischemic cardiomyopathy, including viral myocarditis, dilated cardiomyopathy, hypertrophic cardiomyopathy, peripartum cardiomyopathy, etc; 4.Patients with moderate or severe valvular heart disease or a history of valve replacement; 5.Severe liver dysfunction (ALT >= 3 times the upper limit of normal) or renal dysfunction (eGFR < 60 mL/min/1.73 m^2); 6.Patients complicated with malignant tumors or other diseases with an expected survival time of less than 1 year;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cumulative incidence of MACE; | — |
Secondary
| Measure | Time frame |
|---|---|
| The incidence rate of MACE events (including all-cause death, myocardial infarction, and stroke);Cardiovascular death;Psychogenic readmission;Bleeding incidence rate (BARC classification);Quality of life;Blood pressure, heart rate, blood lipid, and blood sugar compliance rates; | — |
Countries
China
Contacts
Public ContactXu Bing
Northern Jiangsu People's Hospital
Outcome results
None listed